These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 17220355)
1. Vitamin E analogs, a novel group of "mitocans," as anticancer agents: the importance of being redox-silent. Neuzil J; Tomasetti M; Zhao Y; Dong LF; Birringer M; Wang XF; Low P; Wu K; Salvatore BA; Ralph SJ Mol Pharmacol; 2007 May; 71(5):1185-99. PubMed ID: 17220355 [TBL] [Abstract][Full Text] [Related]
2. Vitamin E analogues as anticancer agents: lessons from studies with alpha-tocopheryl succinate. Wang XF; Dong L; Zhao Y; Tomasetti M; Wu K; Neuzil J Mol Nutr Food Res; 2006 Aug; 50(8):675-85. PubMed ID: 16835868 [TBL] [Abstract][Full Text] [Related]
3. Vitamin E analogs trigger apoptosis in HER2/erbB2-overexpressing breast cancer cells by signaling via the mitochondrial pathway. Wang XF; Witting PK; Salvatore BA; Neuzil J Biochem Biophys Res Commun; 2005 Jan; 326(2):282-9. PubMed ID: 15582575 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. Neuzil J; Wang XF; Dong LF; Low P; Ralph SJ FEBS Lett; 2006 Oct; 580(22):5125-9. PubMed ID: 16979626 [TBL] [Abstract][Full Text] [Related]
5. Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria. Neuzil J; Dong LF; Ramanathapuram L; Hahn T; Chladova M; Wang XF; Zobalova R; Prochazka L; Gold M; Freeman R; Turanek J; Akporiaye ET; Dyason JC; Ralph SJ Mol Aspects Med; 2007; 28(5-6):607-45. PubMed ID: 17499351 [TBL] [Abstract][Full Text] [Related]
6. Vitamin E analogues as mitochondria-targeting compounds: from the bench to the bedside? Zhao Y; Neuzil J; Wu K Mol Nutr Food Res; 2009 Jan; 53(1):129-39. PubMed ID: 19072740 [TBL] [Abstract][Full Text] [Related]
7. Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress. Dong LF; Swettenham E; Eliasson J; Wang XF; Gold M; Medunic Y; Stantic M; Low P; Prochazka L; Witting PK; Turanek J; Akporiaye ET; Ralph SJ; Neuzil J Cancer Res; 2007 Dec; 67(24):11906-13. PubMed ID: 18089821 [TBL] [Abstract][Full Text] [Related]
8. Alpha-tocopheryl succinate epitomizes a compound with a shift in biological activity due to pro-vitamin-to-vitamin conversion. Neuzil J Biochem Biophys Res Commun; 2002 May; 293(5):1309-13. PubMed ID: 12054655 [TBL] [Abstract][Full Text] [Related]
9. Vitamin E and cancer. Kline K; Lawson KA; Yu W; Sanders BG Vitam Horm; 2007; 76():435-61. PubMed ID: 17628185 [TBL] [Abstract][Full Text] [Related]
10. Hepatic processing determines dual activity of alpha-tocopheryl succinate: a novel paradigm for a shift in biological activity due to pro-vitamin-to-vitamin conversion. Neuzil J; Massa H Biochem Biophys Res Commun; 2005 Feb; 327(4):1024-7. PubMed ID: 15652498 [TBL] [Abstract][Full Text] [Related]
11. Mitochondria as targets for cancer therapy. Ralph SJ; Neuzil J Mol Nutr Food Res; 2009 Jan; 53(1):9-28. PubMed ID: 19123183 [TBL] [Abstract][Full Text] [Related]
12. Tocopherol-associated protein-1 accelerates apoptosis induced by alpha-tocopheryl succinate in mesothelioma cells. Neuzil J; Dong LF; Wang XF; Zingg JM Biochem Biophys Res Commun; 2006 May; 343(4):1113-7. PubMed ID: 16579965 [TBL] [Abstract][Full Text] [Related]
13. The role of alpha tocopheryl succinate (α-TOS) as a potential anticancer agent. Angulo-Molina A; Reyes-Leyva J; López-Malo A; Hernández J Nutr Cancer; 2014; 66(2):167-76. PubMed ID: 24364743 [TBL] [Abstract][Full Text] [Related]
14. Vitamin E amides, a new class of vitamin E analogues with enhanced proapoptotic activity. Tomic-Vatic A; Eytina J; Chapman J; Mahdavian E; Neuzil J; Salvatore BA Int J Cancer; 2005 Nov; 117(2):188-93. PubMed ID: 15900584 [TBL] [Abstract][Full Text] [Related]
15. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Pathania D; Millard M; Neamati N Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393 [TBL] [Abstract][Full Text] [Related]
19. Vitamin E analogues and immune response in cancer treatment. Tomasetti M; Neuzil J Vitam Horm; 2007; 76():463-91. PubMed ID: 17628186 [TBL] [Abstract][Full Text] [Related]
20. Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity. Neuzil J Br J Cancer; 2003 Nov; 89(10):1822-6. PubMed ID: 14612885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]